Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Deferred Taxes: 2016-2019

Historic Deferred Taxes for Assembly Biosciences (ASMB) over the last 2 years, with Dec 2019 value amounting to -$767,000.

  • Assembly Biosciences' Deferred Taxes fell 167.28% to -$767,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$800,000, marking a year-over-year increase of 89.87%. This contributed to the annual value of -$2.5 million for FY2021, which is N/A change from last year.
  • Assembly Biosciences' Deferred Taxes amounted to -$767,000 in Q4 2019, which was down 5,013.33% from -$15,000 recorded in Q3 2019.
  • In the past 5 years, Assembly Biosciences' Deferred Taxes registered a high of $1.1 million during Q4 2018, and its lowest value of -$9.0 million during Q4 2017.
  • Moreover, its 3-year median value for Deferred Taxes was -$15,000 (2019), whereas its average is -$970,054.
  • Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 1,355.43% in 2017, then spiked by 112.67% in 2018.
  • Over the past 4 years, Assembly Biosciences' Deferred Taxes (Quarterly) stood at -$618,000 in 2016, then crashed by 1,355.43% to -$9.0 million in 2017, then soared by 112.67% to $1.1 million in 2018, then crashed by 167.28% to -$767,000 in 2019.
  • Its Deferred Taxes was -$767,000 in Q4 2019, compared to -$15,000 in Q3 2019 and -$11,000 in Q2 2019.